Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass E, Marsh M, Mangione C, Bressler N, et al. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass E, Marsh M, Mangione C, Bressler N, et al
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • More than 2.7 million Americans age 40 and older have glaucoma—2,719,379.  
  • Low vision or blindness affects 1 in 28 Americans over the age of 40– 3.3 million Americans.  
  • Visual impairment and blindness account for $8 billion in lost productivity annually.  
  • Even mild visual impairment more than doubles the risk of mortality over a 5-year period.  
  • An estimated 4.1 million Americans currently have diabetic retinopathy. That number is expected to grow to 7.2 million by 2020.